DN
DNA Group (T.R.) Ltd.
DNA | TA
Overview
Corporate Details
- ISIN(s):
- IL0011038523
- LEI:
- Country:
- Israel
- Address:
- Shimon Hatars' 43, 6249245 Tel Aviv
- Website:
- http://www.dnas.co.il
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
DNA Group develops and markets technological solutions for defense and homeland security sectors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-10 18:41 |
M&A Activity
Following the completion of a Big Allotment and in light of the company's compl…
|
English | 156.3 KB | ||
| 2025-11-10 17:02 |
Regulatory News Service
Zero Weight Cap Factor in TASE Indices
|
English | 116.1 KB | ||
| 2025-11-10 16:10 |
Delisting Announcement
Base price of 1 agora and unlimited price fluctuation
|
English | 91.6 KB | ||
| 2022-11-06 14:35 |
Regulatory News Service
Changes in the company's names and security names , effective as of f November …
|
Hebrew (modern) | 149.0 KB | ||
| 2021-07-29 21:13 |
Regulatory News Service
Termination of coverage report
|
Hebrew (modern) | 174.5 KB | ||
| 2021-07-29 21:13 |
Notice of Dividend Amount
Termination of coverage report
|
Russian | 101.2 KB | ||
| 2021-06-13 10:10 |
Regulatory News Service
update Analysis (FROST) following financial report, target price remains at NIS…
|
English | 1.1 MB | ||
| 2021-06-13 10:10 |
Investor Presentation
update Analysis (FROST) following financial report, target price remains at NIS…
|
Russian | 101.2 KB | ||
| 2021-04-11 22:23 |
Earnings Release
update Analysis (FROST) following financial report 2020,target price remains at…
|
English | 1.1 MB | ||
| 2021-04-11 22:23 |
Pre-Annual General Meeting Information
update Analysis (FROST) following financial report 2020,target price remains at…
|
Russian | 98.1 KB | ||
| 2020-12-16 19:22 |
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
|
English | 1.1 MB | ||
| 2020-12-16 19:22 |
Investor Presentation
Analysis update following financial report:price target is unchanged NIS 2.62
|
Russian | 94.7 KB | ||
| 2020-09-01 21:58 |
Regulatory News Service
Analysis update following financial report:price target is unchanged NIS 2.62
|
English | 1.1 MB | ||
| 2020-09-01 21:58 |
Environmental & Social Information
Analysis update following financial report:price target is unchanged NIS 2.62
|
Russian | 94.7 KB | ||
| 2020-08-24 21:06 |
Earnings Release
update analsis (FORST),price target is unchanged
|
English | 1.1 MB |
Automate Your Workflow. Get a real-time feed of all DNA Group (T.R.) Ltd. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for DNA Group (T.R.) Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DNA Group (T.R.) Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Develops proprietary drone tech for logistics, security & military and consolidates the industry.
France
ALDR
France
ALDR
Developing pharmaceuticals for urological oncology using its proprietary GuaDex technology platform.
Sweden
DEX
Sweden
DEX
Develops sustainable tech for EV drivetrains and next-gen energy storage materials.
United Kingdom
DGI
United Kingdom
DGI
Developing next-gen potency drugs for erectile dysfunction and premature ejaculation.
Sweden
DICOTBT
Sweden
DICOTBT
A deep-tech factory building Physical AI ventures for mobility, logistics, and automation.
Italy
E9IA
Italy
E9IA
Spain
EEP
CRO offering preclinical drug profiling, screening & pharmacology testing for pharma/biotech.
France
ALECR
France
ALECR
Germany
EVT
Develops myeloid cell-targeting immunotherapies for solid and hematological cancers.
Finland
FARN
Finland
FARN